Alto Pharmacy

Alto Pharmacy

Alto Pharmacy was founded in 2015 by Matt Gamble-Assmann and co-founders who began by shadowing an independent pharmacy in San Francisco’s Mission District to learn the trade. The company was built as a technology-enabled alternative to traditional retail pharmacies, emphasizing personal relationships and insurance navigation (per the firm’s website, 2025). Alto operates as a direct-to-consumer pharmacy platform, integrating prescription delivery, medication bundling, and real-time insurance cost checks. The company covers fertility medication delivery nationwide and offers same-day delivery in multiple cities. Key asset classes include digital services, healthcare logistics, and proprietary adherence technology. Venture capital funding has been led by firms such as Greenoaks Capital, SoftBank Vision Fund, and Transformation Capital (per news reports, 2021–2022). Deal flow is sourced through patient acquisition and provider partnerships. The company employs a team that includes pharmacists, engineers, and care specialists. It has raised over $450M in equity to date (per news reports, 2022). A recent operational event: Alto Pharmacy has continued expanding its provider network and its geographic service area for same-day delivery through 2024. The company reports 70% patient adherence and $79M in drug savings (per the firm’s website, 2025). Alto’s structural differentiator is its full-service technology stack that bundles prescription management, adherence tracking, and cost savings into a single platform. Unlike traditional retail pharmacies, Alto does not operate physical storefronts, instead relying on central fulfillment and proprietary logistics.